Pfizer

Overview

They are a massive global player in healthcare with high pay and strong benefits, though navigating the scale and management can be a challenge. Based in New York, they operate in the biotech and pharmaceuticals industry and maintain a global footprint with over 30 office locations. As a mature public company with over 100,000 employees, they maintain a significant presence in the market and a steady pace of hiring across clinical and technical departments. Their current focus is on non-COVID product growth to offset declining vaccine sales. People generally join for the stability and the high-stakes mission of scientific discovery.

About Pfizer

At Pfizer, we apply science and our global resources to bring treatments and therapies to people all over the globe. Every day, we work to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. For more than 150 years, we’ve worked to make a difference for all who rely on us. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. Pfizer, a global leader in the biopharmaceutical industry is continuously seeking fresh new talent to join our brilliant community and share our vision for the development of innovative therapies that make the world a healthier place.

What to consider

• Low management ratings: CEO and senior management ratings are significantly lower than other culture scores, reflecting a disconnect between leadership and staff.
• Frequent restructuring: Ongoing multibillion-dollar cost-cutting programs and recent layoff rounds have created a stressful environment for long-term career planning.

Signals

• Strong non-COVID growth: Non-COVID products grew 18% in Q2 2026, helping the company raise its full-year revenue guidance.
• Solid benefits rating: The company maintains a high compensation and benefits rating of 76.
• Low leadership approval: The CEO rating sits at 50, with senior management rated at 62, indicating internal dissatisfaction.
• Significant impairment charge: Financial results for Q2 2026 included a $4.3 billion impairment charge related to weaker product performance.

Technology & focus

They build and scale advanced biopharmaceutical manufacturing systems and clinical data platforms to accelerate drug discovery. The technical environment involves complex challenges in automation, regulatory compliance, and bioinformatics for therapy development. Engineering teams focus on maintaining high-reliability systems to support global supply chains and large-scale clinical trials.

• Bioinformatics
• Manufacturing Automation
• Data Analytics
• Cloud Infrastructure
• Digital Health

Why people join & leave

Why people join

• Excellent compensation and 401(k) contributions
• Opportunity to work on life-changing therapies
• Robust global resources and job stability

Why people leave

• Poor morale following multiple layoff rounds
• Hierarchical and out-of-touch management
• Inefficient and antiquated software systems